OPKO Health, Inc. (OPK)
1.255
-0.04
(-3.46%)
USD |
NASDAQ |
Dec 31, 15:08
OPKO Health EPS Diluted (Quarterly): 0.0277 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Stryker Corp. | 2.221 |
| West Pharmaceutical Services, Inc. | 1.928 |
| Solventum Corp. | 7.218 |
| Perspective Therapeutics, Inc. | -0.3495 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 21.63M |
| Revenue (Quarterly) | 151.67M |
| Total Expenses (Quarterly) | 130.04M |
| Enterprise Value | 978.23M |
| Gross Profit Margin (Quarterly) | 20.02% |
| Profit Margin (Quarterly) | 14.26% |
| Earnings Yield | -19.66% |
| Normalized Earnings Yield | -20.69 |